Correlation Between Krebs Biochemicals and Shivalik Bimetal

Can any of the company-specific risk be diversified away by investing in both Krebs Biochemicals and Shivalik Bimetal at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krebs Biochemicals and Shivalik Bimetal into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Krebs Biochemicals and and Shivalik Bimetal Controls, you can compare the effects of market volatilities on Krebs Biochemicals and Shivalik Bimetal and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krebs Biochemicals with a short position of Shivalik Bimetal. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krebs Biochemicals and Shivalik Bimetal.

Diversification Opportunities for Krebs Biochemicals and Shivalik Bimetal

-0.43

Correlation Coefficient

Krebs Biochemicals  Shivalik Bimetal

Very good diversification

The 3 months correlation between Krebs and Shivalik is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Krebs Biochemicals and and Shivalik Bimetal Controls in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shivalik Bimetal Controls and Krebs Biochemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krebs Biochemicals and are associated (or correlated) with Shivalik Bimetal. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shivalik Bimetal Controls has no effect on the direction of Krebs Biochemicals i.e., Krebs Biochemicals and Shivalik Bimetal go up and down completely randomly.

Pair Corralation between Krebs Biochemicals and Shivalik Bimetal

Assuming the 90 days trading horizon Krebs Biochemicals and is expected to generate 2.12 times more return on investment than Shivalik Bimetal. However, Krebs Biochemicals is 2.12 times more volatile than Shivalik Bimetal Controls. It trades about 0.02 of its potential returns per unit of risk. Shivalik Bimetal Controls is currently generating about -0.32 per unit of risk. If you would invest  9,855  in Krebs Biochemicals and on October 25, 2024 and sell it today you would earn a total of  15.00  from holding Krebs Biochemicals and or generate 0.15% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Krebs Biochemicals and  vs.  Shivalik Bimetal Controls

Krebs Biochemicals and

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Shivalik Bimetal Controls

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Shivalik Bimetal Controls has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Krebs Biochemicals and Shivalik Bimetal

The main advantage of trading using opposite Krebs Biochemicals and Shivalik Bimetal positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krebs Biochemicals position performs unexpectedly, Shivalik Bimetal can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shivalik Bimetal will offset losses from the drop in Shivalik Bimetal's long position.

The idea behind Krebs Biochemicals and and Shivalik Bimetal Controls pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.